Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland. Show more

Location: 10 Earlsfort Terrace, Ballycoolin, Dublin, D02 T380, Ireland | Website: https://www.avadel.com | Industry: Drug Manufacturers - Specialty & Generic | Sector: Healthcare

Market Cap

1.242B

52 Wk Range

$6.38 - $16.84

Previous Close

$12.79

Open

$12.88

Volume

1,381,896

Day Range

$12.86 - $13.63

Enterprise Value

1.198B

Cash

81.55M

Avg Qtr Burn

N/A

Insider Ownership

4.89%

Institutional Own.

85.26%

Qtr Updated

06/30/25

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
LUMRYZ (sodium oxybate) Details Excessive daytime sleepiness, Narcolepsy	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LUMRYZ (sodium oxybate) Details Narcolepsy, Excessive daytime sleepiness, Cataplexy	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LUMRYZ (sodium oxybate) Details Idiopathic hypersomnia	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.